These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1945483)
1. In vitro activity of chlorhexidine against enteric rods, pseudomonads and acinetobacter from human periodontitis. Slots J; Rams TE; Schonfeld SE Oral Microbiol Immunol; 1991 Feb; 6(1):62-4. PubMed ID: 1945483 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and antimicrobial susceptibility of Enterobacteriaceae, Pseudomonadaceae and Acinetobacter in human periodontitis. Slots J; Feik D; Rams TE Oral Microbiol Immunol; 1990 Jun; 5(3):149-54. PubMed ID: 2080069 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group. Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641 [TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial sensitivity of enteric rods and pseudomonads from advanced adult periodontitis. Slots J; Feik D; Rams TE Oral Microbiol Immunol; 1990 Oct; 5(5):298-301. PubMed ID: 2098705 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis. Ardila CM; Fernández N; Guzmán IC J Periodontol; 2010 Feb; 81(2):292-9. PubMed ID: 20151809 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics. Qadri SM; Belobraydic KA Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346 [TBL] [Abstract][Full Text] [Related]
7. Subgingival occurrence and antimicrobial susceptibility of enteric rods and pseudomonads from Brazilian periodontitis patients. Barbosa FC; Mayer MP; Saba-Chujfi E; Cai S Oral Microbiol Immunol; 2001 Oct; 16(5):306-10. PubMed ID: 11555308 [TBL] [Abstract][Full Text] [Related]
8. In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli. Chong Y; Lee K; Kwon OH J Antimicrob Chemother; 1993 Nov; 32 Suppl B():21-9. PubMed ID: 8150765 [TBL] [Abstract][Full Text] [Related]
9. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]. Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006. Chen WY; Jang TN; Huang CH; Hsueh PR J Microbiol Immunol Infect; 2009 Aug; 42(4):317-23. PubMed ID: 19949755 [TBL] [Abstract][Full Text] [Related]
11. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams]. Vachée A; Devalckenaere A; Husson MO; Izard D Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280 [TBL] [Abstract][Full Text] [Related]